| Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer M Wachowska, A Muchowicz, M Firczuk, M Gabrysiak, M Winiarska, ... Molecules 16 (5), 4140-4164, 2011 | 294 | 2011 |
| BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199 K Bojarczuk, BK Sasi, S Gobessi, I Innocenti, G Pozzato, L Laurenti, ... Blood, The Journal of the American Society of Hematology 127 (25), 3192-3201, 2016 | 129 | 2016 |
| Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion K Wienand, B Chapuy, C Stewart, AJ Dunford, D Wu, J Kim, A Kamburov, ... Blood advances 3 (23), 4065-4080, 2019 | 117 | 2019 |
| Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL K Bojarczuk, K Wienand, JA Ryan, L Chen, M Villalobos-Ortiz, E Mandato, ... Blood, The Journal of the American Society of Hematology 133 (1), 70-80, 2019 | 96 | 2019 |
| B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies K Bojarczuk, M Siernicka, M Dwojak, M Bobrowicz, B Pyrzynska, P Gaj, ... Leukemia 28 (5), 1163-1167, 2014 | 74 | 2014 |
| Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity J Bil, M Winiarska, D Nowis, K Bojarczuk, A Dabrowska-Iwanicka, ... Blood, The Journal of the American Society of Hematology 115 (18), 3745-3755, 2010 | 60 | 2010 |
| HDACi–going through the mechanisms M Wanczyk, K Roszczenko, K Marcinkiewicz, K Bojarczuk, M Kowara, ... Front Biosci 16 (1), 340-359, 2011 | 59 | 2011 |
| Approaches to improve photodynamic therapy of cancer M Firczuk, M Winiarska, A Szokalska, M Jodlowska, M Swiech, ... Front Biosci 16 (1), 208-24, 2011 | 58 | 2011 |
| HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies M Bobrowicz, M Dwojak, B Pyrzynska, J Stachura, A Muchowicz, ... Blood, The Journal of the American Society of Hematology 130 (14), 1628-1638, 2017 | 50 | 2017 |
| B-cell receptor signaling in the pathogenesis of lymphoid malignancies K Bojarczuk, M Bobrowicz, M Dwojak, N Miazek, P Zapala, A Bunes, ... Blood Cells, Molecules, and Diseases 55 (3), 255-265, 2015 | 43 | 2015 |
| FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy B Pyrzynska, M Dwojak, A Zerrouqi, G Morlino, P Zapala, N Miazek, ... Oncoimmunology 7 (5), e1423183, 2018 | 31 | 2018 |
| The mutual interactions between mesenchymal stem cells and myoblasts in an autologous co-culture model A Kulesza, A Burdzinska, I Szczepanska, W Zarychta-Wisniewska, ... PLoS One 11 (8), e0161693, 2016 | 31 | 2016 |
| Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity M Winiarska, D Nowis, J Bil, E Glodkowska-Mrowka, A Muchowicz, ... Journal of Biological Chemistry 287 (38), 31983-31993, 2012 | 29 | 2012 |
| CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas L Chen, J Ouyang, K Wienand, K Bojarczuk, Y Hao, B Chapuy, ... Haematologica 105 (5), 1361, 2020 | 26 | 2020 |
| Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies M Winiarska, K Bojarczuk, B Pyrzynska, J Bil, M Siernicka, M Dwojak, ... MAbs 6 (5), 1300-1313, 2014 | 21 | 2014 |
| Application of a proteomic approach to identify proteins associated with primary graft non-function after liver transplantation O Kornasiewicz, K Bojarczuk, M Bugajski, J Golab, M Krawczyk International Journal of Molecular Medicine 30 (4), 755-764, 2012 | 12 | 2012 |
| Destruction of a microtubule-bound MYC reservoir during mitosis contributes to vincristine's anticancer activity S Becker, C Kiecke, E Schäfer, U Sinzig, L Deuper, P Trigo-Mourino, ... Molecular Cancer Research 18 (6), 859-872, 2020 | 9 | 2020 |
| Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins M Dwojak, M Bobrowicz, J Bil, K Bojarczuk, B Pyrzynska, M Siernicka, ... Blood Cancer Journal 5 (4), e300-e300, 2015 | 5 | 2015 |
| Molecular classification of large B-cell non-hodgkin lymphoma K Bojarczuk, K Wienand, B Chapuy The Cancer Journal 26 (4), 357-361, 2020 | 2 | 2020 |
| Molecular classification of aggressive B-cell lymphoma K Bojarczuk, B Chapuy HemaSphere 3, 116-118, 2019 | 1 | 2019 |
Magdalena WiniarskaThe Medical Univeristy of WarsawVerified email at wum.edu.pl
